Last updated July 2026
AI engines now answer a large share of the questions patients and HCPs type before they ever read a package insert or click a brand page. Those answers draw heavily from third-party sources, and the sources they pick follow a consistent, documented pattern: peer-reviewed databases, major health portals, and editorial health media dominate. Your brand page is almost never in the mix.
That pattern is both a risk and an opportunity. This playbook gives pharma brand and medical affairs teams a repeatable method for auditing what AI engines say, mapping where those answers come from, and building the source-attribution table your compliance team needs to act.
Why third-party sources dominate drug queries
AI engines running retrieval-augmented generation pull sources at inference time. For health and drug queries, the retrieval layer consistently surfaces:
- PubMed abstracts and full-text articles
- Mayo Clinic condition and drug pages
- WebMD drug summaries and condition guides
- MedlinePlus, Drugs.com, and similar formulary databases
- Major health journalism outlets (Healthline, Everyday Health, Verywell Health)
Brand-owned pages, Prescribing Information PDFs, and patient assistance portals appear rarely, if at all.
This is not an accident. Multiple citation studies confirm that the large majority of AI citations in health-adjacent queries come from third-party, non-commercial sources. An analysis by Omniscient Digital of more than 23,000 AI citations found that roughly 77% come from non-owned sources, with brand-owned domains accounting for approximately 23% (Omniscient Digital, 2025). That skew is more pronounced in healthcare, where models apply additional trust filters for YMYL (your money or your life) content.
The practical implication: if you want to appear in AI answers about your drug, you need to appear in the sources AI engines trust. That means earning citations in peer-reviewed publications, formulary databases, and reputable health editorial. It also means writing those placements in a structure that AI engines can lift cleanly.
The 40-60 word passage structure that AI engines quote
Before auditing where you currently stand, understand the passage structure that determines what gets quoted.
AI engines favor passages structured as: Subject + Claim + Metric + Source + Year.
A passage optimized for AI citation looks like this:
“[Drug A] reduced systolic blood pressure by 12 mmHg versus placebo at 24 weeks in a randomized, double-blind trial of 847 adults with hypertension (Journal of the American Medical Association, 2025).”
That is 39 words. It is self-contained. It contains a subject, a specific claim, a quantified metric, an attribution source, and a year. A model can insert that passage into an answer without paraphrasing it, which eliminates the hallucination risk that comes from compression.
Passages that fail this test:
- Marketing prose: “The leading treatment option for patients who need reliable control…” (no metric, no source)
- Overlong summaries: Anything above 80 words gets compressed and paraphrase-errors appear
- Passive or hedged language: “May reduce…”, “Has been shown to possibly…” (models route around uncertainty signals)
According to an analysis by Kevin Indig of 1.2 million ChatGPT responses (February 2026), 44.2% of citations were drawn from the first 30% of a page’s content. Front-loading your key claim-metric-source passage is not optional; it is structural. Note that this finding is specific to ChatGPT and has not been replicated at the same scale across all AI systems.
Step 1: Build your prompt set
A pharma AI audit starts with a prompt set that maps to how real patients and HCPs actually phrase queries. Do not use marketing phrasing. Use the language of someone who has just been diagnosed or is comparing treatment options.
Prompt categories for drug brands:
| Category | Example prompt |
|---|---|
| Drug comparison | ”How does [Drug A] compare to [Drug B] for [condition]?” |
| Mechanism of action | ”How does [Drug A] work?” |
| Side effects | ”What are the side effects of [Drug A]?” |
| Dosing | ”What is the recommended dose of [Drug A] for adults?” |
| Condition-first | ”What are the treatment options for [condition]?” |
| Patient suitability | ”Is [Drug A] safe for patients with [comorbidity]?” |
| Cost/access | ”Is [Drug A] covered by Medicare?” |
Build five to seven variants per category. Use phrasing you would actually find in a patient forum or HCP community. AI engines are probabilistic, so run each prompt a minimum of five times and record all responses before drawing conclusions. A single response is not a signal.
Step 2: Run the audit across engines
Run your prompt set across at minimum ChatGPT and Perplexity. Add Google AI Overviews and Gemini for full coverage. Do not rely on a single engine. According to research by BrightEdge, brand mentions disagree 61.9% of the time across Google AI Overviews, AI Mode, and ChatGPT, with only 33.5% of queries producing the same brand names across all three (BrightEdge AI Catalyst research, July 2025). That engine-level inconsistency is especially pronounced in healthcare.
For each prompt response, record:
- Whether your brand is mentioned (yes/no)
- The exact language used to describe your drug
- Every source cited (domain and, where visible, specific URL)
- The framing: is the mention positive, neutral, or negative?
- Whether any factual claim is inaccurate
Tools that make this systematic at scale: Profound covers 9+ AI engines and provides citation maps that show exactly which domains the engine pulled for each prompt. Peec AI supports multi-brand and multi-market monitoring with unlimited seats, useful for pharma teams covering a portfolio of drugs across international markets. Semrush surfaces organic citation signals that overlap significantly with what AI retrieval layers favor. Temso, an all-in-one AI SEO platform from $89/mo, tracks brand mentions, sentiment, and citations across 8 engines and suits teams that want monitoring and a remediation queue in one place.
See the full AI visibility tool ranking for a scored comparison.
Step 3: Build your source-attribution table
The audit output your MLR team needs is a source-attribution table. It maps each prompt category to the domains that AI engines actually cite, and it shows whether your brand appears and what is said about it.
Source-attribution table template:
| Prompt category | Engine | Top cited domains | Your drug mentioned? | Sentiment | Accuracy issues |
|---|---|---|---|---|---|
| Drug comparison (vs. competitor) | ChatGPT | pubmed.ncbi.nlm.nih.gov, mayoclinic.org, drugs.com | Yes | Neutral | None found |
| Drug comparison (vs. competitor) | Perplexity | drugs.com, webmd.com, everydayhealth.com | No | N/A | N/A |
| Side effects | ChatGPT | fda.gov, mayoclinic.org, rxlist.com | Yes | Neutral | Outdated contraindication listed |
| Side effects | Perplexity | webmd.com, medlineplus.gov, healthline.com | Yes | Neutral | None found |
| Condition-first (treatment options) | ChatGPT | uptodate.com, nejm.org, mayoclinic.org | No | N/A | N/A |
| Mechanism of action | ChatGPT | pubmed.ncbi.nlm.nih.gov, britannica.com, drugs.com | Yes | Positive | None found |
Populate this table for every prompt category and every engine you track. Update it quarterly. When your drug is not mentioned in a condition-first query, the table tells you which domains you need to earn placements in. When an accuracy issue appears, the table tells you which source the engine pulled from, so you can contact that publisher or update your own PubMed-indexed abstracts.
This table is also the artifact you bring to MLR review. It shows exactly what AI engines say about your drug, with sourcing, so the review is scoped and actionable rather than open-ended.
Step 4: Identify which sources you can earn
Once you have the source-attribution table, map each cited domain to the influence pathway available to you.
Source influence pathways:
| Source type | Examples | Influence pathway |
|---|---|---|
| Peer-reviewed journals | PubMed, NEJM, JAMA, Lancet | Publish or co-author studies; ensure abstracts use the 40-60 word passage structure |
| Formulary databases | Drugs.com, RxList, MedlinePlus | Submit corrections via publisher contact forms; update FDA label pages |
| Health portals | Mayo Clinic, WebMD, Healthline | Pitch drug profile updates via medical communications; earned editorial |
| Government sources | FDA.gov, CDC.gov, NIH.gov | Submit updated label information; post clinical trial results on ClinicalTrials.gov |
| Health journalism | Everyday Health, Verywell Health, Medscape | Medical communications outreach for condition-first editorial |
You cannot control what AI engines say. You can control what the sources they trust say. Every action on this list is an earned citation strategy, not a direct AI optimization. That distinction is important for MLR: you are pursuing standard medical communications and publication planning, applied to the sources that AI engines retrieve.
Step 5: Structure your existing content for AI retrieval
Your brand website, prescribing information pages, and disease education content can be structured to improve the probability that AI engines pull and accurately represent your content, even when they do not cite it as a primary source.
Apply the Subject + Claim + Metric + Source + Year structure to:
- Mechanism of action summaries
- Clinical trial result pages (efficacy and safety data)
- Dosing and administration pages
- FAQ sections on your HCP portal
Each of those pages should open with a 40-60 word passage that contains a self-contained factual claim with a metric and a source. According to Kevin Indig’s 2026 analysis of 1.2 million ChatGPT responses, 44.2% of citations came from the first 30% of a page’s content. Your opening passage is the highest-value real estate on any health content page.
Step 6: Monitor for drift
A single audit is a snapshot. Drift is the signal.
Set up weekly prompt sampling for your five highest-priority queries. Track month-over-month change in:
- Mention rate (what share of runs mention your drug)
- Sentiment polarity (positive, neutral, negative)
- Source composition (which domains are cited this month versus last month)
- Accuracy flags (have any new inaccuracies appeared)
Platforms like Profound provide automated tracking across 9+ engines with citation-level attribution, making this continuous monitoring feasible without manual logging. Peec AI supports daily prompt-level tracking and actions features that convert gaps into a prioritized queue. Temso builds the monitoring-to-action cycle into one subscription, with sentiment and accuracy monitoring included on every plan.
A competitor approval, a new study publication, or a label update for your drug or a rival are all triggers for an out-of-cycle audit pass. AI engines update their retrieval indexes frequently, and a new highly-cited study can shift citation patterns within weeks.
What the audit will not tell you
Be precise about the limits of this methodology with your MLR and compliance stakeholders.
The audit tells you what AI engines said during the sampling window. It does not tell you what every user sees (AI responses are probabilistic and vary by prompt phrasing, user location, and session context). It does not tell you whether AI answers influenced a prescribing decision or a patient choice. It tells you the sourcing pattern and the current state of your brand representation in AI-generated health answers.
That scoped framing is what makes the audit acceptable to compliance teams. It is an intelligence function, not a promotion function.
Start your audit
The source-attribution table in Step 3 is the deliverable. You can build a first version manually in an afternoon using ChatGPT and Perplexity on 20-30 prompts. That first pass will show you whether your drug is being mentioned, what sources dominate the answers, and where the largest accuracy gaps are.
For ongoing monitoring at scale, platforms like Profound, Peec AI, and Temso automate the prompt-running, source-logging, and sentiment-tracking that would otherwise require manual effort every week.
The full AI visibility tool ranking compares every platform on engine coverage, citation depth, and pricing. The glossary defines the key terms used in AI brand monitoring, including share of voice, citation rate, and sentiment scoring.